|
Clinical pathways improve care of patients with traumatic brain injury. Journal of Trauma 2001 51:369-375. The guidelines for the management of severe head injury were published in 1995. Those patients who were treated according to the pathways had a shorter length of stay in the hospital in the ICU and were on the ventilator for a shorter time.
Estimated migraine prevalence in Sweden exceeds 13%. Cephalgia 2001 21:664-671. No reasons are given for the prevalence of migraines. They occur all over the country. 21% of the population has severe headaches. Migraine attacks 16.7% in women and 9.5% in men, occur about 1.3 times per month usually lasting 19 hours.
NMDA receptor antagonists may retard growth of some malignant gliomas. Nature Medicine 2001 7:994-995 and 1010-1015. While there still is no magic bullet for this horrible disease there are many things that may slow it down. Dizocilipine an N-methyl-D-aspartate (NMDA) receptor antagonist slowed down the growth of a mutant glioma cell line injected into rat brains. Glutamate antagonists are used to treat seizures and may be able to help in slowing down brain tumors. However, this is a rat model and is very different from humans.
Protective tube helps re-grow severed spinal nerves. Reuters Health. Dr. Molly Shoichet presented information at the American Chemical Society meeting that paralyzed rats had some hind-limb function restored after a hydrogel tube filled with chemicals was inserted into the spinal column. The tube acted as scaffolding encouraging nerve re-growth. The (Continued on page 51)
|
|
